STAT December 10, 2024
Allison DeAngelis

Tasca Therapeutics is developing small molecule treatments

Tasca Therapeutics, the first startup created by new VC firm Cure Ventures, has raised $52 million to develop a new breed of cancer therapies.

Tasca is developing...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Investments, Pharma / Biotech, Trends
2025 Drugs to Watch: Market Access, Innovation, and the Future of Reimbursement
Renowned Geneticist Francis Collins, MD, PhD, Retires from NIH
How AI Is Transforming The Pharmaceutical Industry
MHE Week in Review – Medicaid Cuts, Congressional PBM Hearing and More
Former director Francis Collins retires from NIH, urging ‘respect’ for embattled workers

Share This Article